Riskpilot← Back to searchSign inGet full accessHeartBalance Innovations AB
ABActiveOrg 5593732257Toppvägen 10Research and experimental development on natural sciences and engineering · NACE 7210Est. 20220 employees
Revenue 2025
SEK 0
EBITDA margin
—
-112% vs 2024
Equity ratio
69.4%
Financial strength
Net profit 2025
SEK -11K
-112% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -12K | -112% |
| Net profit | SEK -11K | -112% |
| Total assets | SEK 493K | +7% |
| Equity | SEK 342K | -3% |
| Employees | 0 | — |
Legal name
HeartBalance Innovations AB
Org number
5593732257
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30 mars 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska utveckla och sälja medicinska och icke-medicinska produkter och tjänster inom hälsa och medicin. Bolaget ska utföra akademisk och icke-akademisk forskning och utveckling. Bolaget ska erbjuda medicinsk konsultation, hälsotjänster, tekniska tjänster och konsultation inom hälsa och medicin. Bolaget ska erbjuda akademisk och icke-akademisk utbildning inom hälsa och medicin. Bolaget ska utveckla nya kliniker, fitnesscenter, hotell inom området hälsa och medicin.
Address
Toppvägen 10
Email
piamariahauschild@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | — | −0 | — |
| EBITDA | −65 | 104 | −12 |
| Depreciation & amort. | −0 | — | −0 |
| EBIT | −65 | 104 | −12 |
| Net financials | — | 0 | — |
| Profit before tax | −65 | 104 | −11 |
| Tax | −0 | −9 | −0 |
| Net profit | −65 | 95 | −11 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 236 | 459 | 493 |
| Equity | 235 | 353 | 342 |
| Long-term debt | 0 | — | 0 |
| Short-term debt | 1 | 106 | 151 |
| Total debt | 1 | 106 | 151 |
EBITDA margin
-1200000.0%
This company
15.8%
Market median
-7595037% vs market
20232025
Equity ratio
69.4%
This company
38.2%
Market median
+82% vs market
20232025
Return on equity
-3.2%
This company
18.4%
Market median
-117% vs market
20232025
Net profit margin
-1100000.0%
This company
8.1%
Market median
-13580347% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PH Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HeartBalance Innovations AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Hauschild | Deputy Chief Executive Officer | 0 companies |
| Pia-Maria Grafström | Chairman | 0 companies |
| Peter Pasqual Canaris | Deputy Board Member | 0 companies |